Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical...
-
date post
19-Dec-2015 -
Category
Documents
-
view
221 -
download
5
Transcript of Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical...
![Page 1: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/1.jpg)
Eric R. Wright, PhD
Director, Center for Health Policy
An Epidemiological Overview of Nonmedical Prescription
Drug (Rx) Use in Indiana
![Page 2: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/2.jpg)
SPF SIGFunding was provided by the U.S. Department of Health and Human Services’ Center for Substance Abuse Prevention, as part of the Strategic Prevention Framework State Incentive Grant (SPF SIG) Program, and by the Indiana Family and Social Services Administration/Division of Mental Health and Addiction through the SAMHSA Substance Abuse Prevention and Treatment (SAPT) Block Grant CFDA 93.959. The SPF SIG program sponsors initiatives to encourage states to engage in data-based decision-making for substance abuse prevention planning and grant making.
![Page 3: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/3.jpg)
SPF SIG
The Center for Health Policy and the State of Indiana, represented by the Family and Social Services Administration (FSSA), Division of Mental Health and Addiction (DMHA), formed a formal partnership to provide support in executing the SPF SIG, for the period 2006-2010.
The Center for Health Policy’s role is to provide leadership and technical support for the State Epidemiology and Outcomes Workgroup (SEOW), and to develop, implement, and coordinate a statewide program evaluation initiative to assess the impact of new prevention programs funded as part of Indiana's SPF SIG program.
![Page 4: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/4.jpg)
State Epidemiological Profiles• Annual publications (2006-2009) – currently working on
2010 report• Available at www.healthpolicy.iupui.edu • Review of alcohol, tobacco, marijuana, cocaine, heroin,
meth, Rx drugs, and polysubstance abuse• Companion documents
Drug Fact Sheets English Spanish
Chart Pack (CD)
![Page 5: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/5.jpg)
Recent ATOD Issue Briefs What’s Cooking? Meth Use in Indiana (2010)
An Epidemiological Overview of Alcohol, Tobacco, and Other Drug Use in Indiana (2010)
Injection Drug Use In Indiana (2010)
Economic Impact of Substance Abuse and Misuse in Indiana (2010)
Underage Drinking: A Culture of Drinking on Indiana’s College Campuses? (2009)
Prescription Drug Abuse Is a Growing Problem in Indiana (2008)
Fatal Drug Overdoses: A Growing Concern in Indiana (2008)
![Page 6: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/6.jpg)
Most Commonly Abused Rx Drugs• Pain relievers (opioids, narcotics)
Oxycodone (e.g., OxyContin, Percocet), hydrocodone, codeine, and morphine
• Central nervous system depressants (sedatives, tranquilizers, hypnotics)Barbiturates (e.g., Mebaral, Nembutal) and
benzodiazepines (e.g., Valium, Xanax)• Stimulants (used to treat attention deficit disorders,
narcolepsy, and weight loss)Dextroamphetamine (e.g., Dexedrine, Adderall) and
methylphenidate (e.g., Ritalin, Concerta) 1
![Page 7: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/7.jpg)
The INSPECT Program
• INSPECT: Indiana Scheduled Prescription Electronic Collection & Tracking Program
• Indiana’s Rx drug monitoring program• Collects information on all controlled substances
(schedules II-V) dispensed in Indiana• Maintained by the Indiana Professional Licensing
Agency/Board of Pharmacy
![Page 8: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/8.jpg)
Rx Drugs Dispensed in Indiana (INSPECT, 2008)
In 2008, almost 11.5 million controlled substances were dispensed to Indiana residents
53.2% pain relievers30.9% CNS depressants 9.9% stimulants6.2% others
Source: Indiana State Board of Pharmacy, 20102
![Page 9: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/9.jpg)
Rx Drugs Dispensed, by Gender
Note: results were significant, P < .001.Source: Indiana State Board of Pharmacy, 20102
OpioidsCNS
Depressants StimulantsMale 54.6% 25.7% 13.7%Female 52.3% 34.3% 7.4%
![Page 10: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/10.jpg)
Rx Drugs Dispensed, by Age Group
Age Group Opioids
CNS Depressants Stimulants
0-17 23.3% 5.7% 68.6%18-25 61.6% 17.6% 17.3%26-35 61.2% 27.1% 7.4%36-45 56.0% 32.1% 6.1%46-55 54.3% 34.6% 4.3%56-65 53.4% 35.9% 2.9%65+ 52.4% 39.3% 1.1%
Note: results were significant, P < .001.Source: Indiana State Board of Pharmacy, 20102
![Page 11: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/11.jpg)
The Growing Problem of Prescription Rx Abuse• Abuse of Rx drugs is a serious and growing
public health problem in Indiana and the U.S.• Almost 52 million Americans (20.8%) ages 12+
have used Rx drugs nonmedically at least once in their life; this includes pain relievers, sedatives, tranquilizers, and stimulants (2008).
• In Indiana, over a million Hoosiers (20.7%)
reported that they misused Rx drugs at least once in their life (2002-2004)3
![Page 12: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/12.jpg)
Lifetime, Past Year, and Current Nonmedical Rx Drug Use, Indiana and U.S. (National Survey on Drug Use and Health)
Lifetime Use Past Year Use
Past Month Use
Indiana U.S. Indiana U.S. Indiana U.S. All Psycho-therapeutics
20.7% 20.8% 7.6% 6.1% 2.7% 2.5%
Pain Relievers 15.0% 14.0% 6.1% 4.8% 2.0% 1.9%
OxyContin 2.5% 1.9% 0.8% 0.6% 0.3% 0.2%
Tranquilizers 9.1% 8.6% 2.8% 2.0% 0.8% 0.7%
Sedatives 3.9% 3.6% 0.4% 0.2% 0.1% 0.1%
Stimulants 8.3% 8.5% 1.7% 1.1% 0.8% 0.4%
Note: Indiana data based on NSDUH averages from 2002-2004 (most recent estimates); U.S. data based on 2008 results.Source: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, n.d.3
![Page 13: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/13.jpg)
Nonmedical Pain Reliever Use in the Past Year, Indiana and U.S., by Age Group (NSDUH, 2008)
Source: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, n.d.3
12 -17 18-25 26 and older
Indiana 0.0766 0.1416 0.0444
U.S. 0.0656 0.1205 0.0344
3%
8%
13%
18%
![Page 14: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/14.jpg)
Youth Consumption Patterns• Most 12th grade students received narcotics from a friend
or relative—given for free, purchased, or stolen• Teenagers of middle- and upper-class socioeconomic
status are most likely to abuse these substances by crushing and snorting the tablets1
• Pain relievers such as OxyContin and Vicodin are the most commonly abused prescription drugs by teens
Image Source: http://www.visionsteen.com/blog/labels/East-Seattle.html
![Page 15: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/15.jpg)
Special Focus: Oxycodone
• Oxycodone (and its forms) is one of the most widely abused prescription pain relievers in Indiana
Image Source: http://www.justice.gov/dea/photos/oxy/e710_pile.jpg
![Page 16: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/16.jpg)
Oxycodone Distribution
• Oxycodone (e.g., OxyContin) distribution to retail registrants in Indiana (pharmacies, hospitals, and practitioners) nearly doubled from about 29 million dosage units in 2002 to a projected 54 million in 20074
![Page 17: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/17.jpg)
Schedule II Narcotics
Oxycodone (and its forms) is listed as a Schedule II Narcotic by the U.S. Drug Enforcement Administration
(A) The drug or other substance has a high potential for abuse
(B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions
(C) Abuse of the drug or other substances may lead to severe psychological or physical dependence 5
![Page 18: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/18.jpg)
Oxycodone Distribution to Indiana Retail Registrants, January 1, 2007, through June 30, 2008
Source: U.S. Drug Enforcement Administration, 20084
![Page 19: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/19.jpg)
Rx Use Reported at Admission (TEDS, 2009)FREQUENCY
Indiana Family and Social Services Administration, Revenue Enhancement and Data, 20106
![Page 20: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/20.jpg)
Indiana Family and Social Services Administration, Revenue Enhancement and Data, 20106
Rx Use Reported at Admission (TEDS, 2009)PERCENTAGE
![Page 21: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/21.jpg)
Indiana Family and Social Services Administration, Revenue Enhancement and Data, 20106
Rx Use Reported at Admission (TEDS, 2009)RATE
![Page 22: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/22.jpg)
Percentage of Indiana and U.S. Treatment Episodes with Nonmedical Rx Drug Use (TEDS, 2008)
Source: Substance Abuse and Mental Health Data Archive, n.d.7
ALL RX USE
All Prescription Drugs Pain Relievers Sedatives & Tranquilizers StimulantsIndiana 0.189 0.137 0.073 0.01U.S. 0.14 0.102 0.041 0.012
3%
8%
13%
18%
![Page 23: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/23.jpg)
Source: Substance Abuse and Mental Health Data Archive, n.d.7
Percentage of Indiana and U.S. Treatment Episodes with Nonmedical Rx Drug Dependence (TEDS, 2008)
ALL RX DEPENDENCE
All Prescription Drugs Pain Relievers Sedatives & Tranquilizers StimulantsIndiana 0.096 0.078 0.016 0.003U.S. 0.071 0.059 0.008 0.004
1%
3%
5%
7%
9%
![Page 24: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/24.jpg)
Number of Arrests for Possession and Sale/ Manufacture of “Other Drugs” (Barbiturates and Benzedrine) in Indiana (Uniform Crime Reporting Program, 1999–2007)
1999 2000 2001 2002 2003 2004 2005 2006 2007Possession 1617 1255 1493 1621 1688 2191 2620 2643 2720Sale 316 528 537 476 556 659 746 767 690
250
750
1,250
1,750
2,250
2,750
Source: National Archive of Criminal Justice Data, Inter-university Consortium for Political and Social Research, University of Michigan, n.d.8
1999 2000 2001 2002 2003 2004 2005 2006 2007Possession 1617 1255 1493 1621 1688 2191 2620 2643 2720Sale 316 528 537 476 556 659 746 767 690
250
750
1,250
1,750
2,250
2,750
![Page 25: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/25.jpg)
Arrest Rates, per 1,000 Population, for Possession and Sale/Manufacture of “Other Drugs” (Barbiturates and Benzedrine), Indiana and U.S. (Uniform Crime Reporting Program, 1999–2007)
1999 2000 2001 2002 2003 2004 2005 2006 2007Indiana Possession
0.272084805653712
0.206398009369318
0.244163902174171
0.263189170829093
0.272449526223509
0.351258639383388
0.41773139010643
0.418625426069768
0.43
U.S. Possession
0.522617174750906
0.555146911815813
0.587248442921008
0.648572476644375
0.757488285005328
0.86098132389521
0.948937676290203
0.921374067741191
0.860000000000001
Indiana Sale
0.0531717987548376
0.0868351784438248
0.087820506006383
0.0772844203051501
0.0897404837560848
0.105650133890302
0.118941838557022
0.121485320391794
0.11
U.S. Sale
0.132061564188037
0.175835076164741
0.172090581212229
0.148705460912077
0.171397262990242
0.174597223438392
0.219678523834811
0.173634813148771
0.15
0.10
0.30
0.50
0.70
0.90
1.10
Per 1
,000 P
opula
tion
Source: National Archive of Criminal Justice Data, Inter-university Consortium for Political and Social Research, University of Michigan, n.d.8
![Page 26: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/26.jpg)
How Do People Illegally Obtain Rx Drugs?
• Receiving/purchasing/stealing medication from family or friends
• Receiving extra amounts of a medication when physicians overprescribe (either intentionally or negligently)
• “Doctor Shopping”• Illegal online pharmacies• Theft and burglaries (from residences and
pharmacies)9
![Page 27: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/27.jpg)
Estimated Costs/Allocations Attributableto Substance Use (Indiana, FY 2008)• Funding to Reduce Substance Use
Prevention, Intervention and Research: $70 million• Funding to Address Consequences of Substance Use
Healthcare costs/Medicaid and Medicare: $4.8 billion Corrections and Judiciary: $1.3 billion Education: $621 million Child welfare: $685 million Income support: $133 million Mental health: $126 million Developmental disabilities/FASD: $11 million Public safety: $60 million State workforce: $7 million
• Net Gain from Substance Use Excise taxes for alcohol, tobacco, and controlled substances: $567 million
TOTAL IMPACT:$7.3 BILLION
![Page 28: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/28.jpg)
Federal, State, and Local Spending/Funding (Per Capita) Attributable to Substance Use in Indiana Compared to Illinois, Michigan, Ohio, and Kentucky
Indiana FY 2008
4-State Average Adjusted for Inflation
FY 2008
Healthcare $756.47 $830.74
Income Support, Child Welfare $128.85 $197.52
Justice, Judiciary, Regulation + Compliance $119.07 $290.79
Education $97.87 $197.67
Mental Health, Developmental Disabilities $21.62 $38.01
Prevention, Intervention, Research $10.99 $35.67
Public Safety, Interdiction $9.50 $88.37
Workforce $1.09 $9.69
TOTAL $1,145.46 $1,688.46 Note: 4-state average is based on 2005 data for Illinois, Michigan, Ohio, and Kentucky, as reported by CASA (2009). 10 We then applied the CPI to adjust for inflation and improve comparability to Indiana.
![Page 29: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/29.jpg)
Conclusions and Some Final Thoughts• Abuse of Rx drugs is a serious and growing public health problem in
Indiana and the U.S.• Opioid-based pain medications (e.g., oxycodone) are the most
frequently abused Rx drug in Indiana.• Pain medications in Indiana are most frequently abused by females,
whites, and young adults (18-25).• Approximately 99% of public spending in Indiana is on the
consequences of the negative consequences of alcohol, tobacco, and other drug use than on prevention.
• Studies suggest that if effective prevention policies and programs were implemented nationwide, substance abuse initiation would decline for 1.5 million youth and be delayed for 2 years on average.11
![Page 30: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/30.jpg)
References1. National Institute on Drug Abuse. (2005). Research report series: Prescription drugs abuse and addiction. Retrieved November
24, 2009, from http://www.nida.nih.gov/ResearchReports/Prescription/Prescription.html
2. Indiana Board of Pharmacy. (2010). 2008 INSPECT dataset. Received May 26, 2010, from Joshua Klatte, Program Director, INSPECT Prescription Monitoring Program, Indiana Board of Pharmacy.
3. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (n.d.). National Survey on Drug Use and Health. Retrieved September 15, 2009, from https://nsduhweb.rti.org/
4. U.S. Drug Enforcement Administration, Office of Enforcement Operations, Pharmaceutical Investigations Section, Targeting and Analysis Unit. (2007). State of Indiana oxycodone purchases 2002-2007. Received September 14, 2007 from Dennis Wichern, in personal e-mail to IU Center for Health Policy
5. 21 USC Sec. 812 01/22/02. Title 21 - Food and Drugs Chapter 13 - Drug Abuse Prevention and Control Subchapter I - Control and Enforcement Part B - Authority to Control; Standards and Schedules. Retrieved March 26, 2010, from http://www.justice.gov/dea/pubs/csa/812.htm
6. Indiana Family and Social Services Administration, Revenue Enhancement and Data. (2009). Substance abuse population by county, 2008. Indianapolis, IN: Indiana Family and Social Services Administration
7. Substance Abuse and Mental Health Data Archive. (2009). Treatment Episode Data Set - Admissions (TEDS-A), 2008. Retrieved September 23, 2009, from http://webapp.icpsr.umich.edu/cocoon/SAMHDA/STUDY/24280.xml
8. National Archive of Criminal Justice Data, Inter-university Consortium for Political and Social Research, University of Michigan. (n.d.). Uniform Crime Reporting Program. Retrieved September 18, 2009, from http://www.icpsr.umich.edu/NACJD/
9. Office of National Drug Control Policy. (n.d.). Prescription drugs. Retrieved November 24, 2009, from http://www.whitehousedrugpolicy.gov/drugfact/prescrptndrgs/index.html
10. National Center on Addiction and Substance Abuse at Columbia University. (2009). Shoveling Up II: The Impact of Substance Abuse on Federal, State, and Local Budgets. Retrieved September 24, 2009, from http://www.casacolumbia.org/absolutenm/articlefiles/380ShovelingUpII.pdf
11. Miller, T., & Hendrie, D. (2009). Substance abuse prevention dollars and cents: A cost-benefit analysis (Vol. DHHS Pub. No. (SMA) 07-4298). Rockville, MD: Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration
![Page 31: Eric R. Wright, PhD Director, Center for Health Policy An Epidemiological Overview of Nonmedical Prescription Drug (Rx) Use in Indiana.](https://reader036.fdocuments.us/reader036/viewer/2022062407/56649d2f5503460f94a06d83/html5/thumbnails/31.jpg)
Center for Health Policy
The Center for Health Policy collaborates with state and local government, as well as public and private healthcare organizations in health policy and program development to conduct high quality program evaluation and applied research on critical health policy-related issues.
Eric R. Wright, PhD
Director, Center for Health Policy
Professor and Division Director for Health Policy and Management
Department of Public Health, IU School of Medicine
Indiana University-Purdue University Indianapolis (IUPUI)
410 W. 10th St. Suite 3100
Indianapolis, IN 46202
317-274-3161
www.healthpolicy.iupui.edu